Relevant bibliographies by topics / Treenut allergy / Journal articles
To see the other types of publications on this topic, follow the link: Treenut allergy.

Journal articles on the topic 'Treenut allergy'

Author: Grafiati
Published: 2 June 2025
Last updated: 31 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 17 journal articles for your research on the topic 'Treenut allergy.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Goldberg, Michael R., Michael Y. Appel, Liat Nachshon, Mor Carmel, Michael B. Levy, and Arnon Elizur. "The Utility of BAT in Diagnosing Treenut Allergy." Journal of Allergy and Clinical Immunology 139, no. 2 (2017): AB276. http://dx.doi.org/10.1016/j.jaci.2016.12.887.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Shen, Jerry, Annaliesse Blincoe, Jenny Heyward, and Kuang-Chih Hsiao. "Factors associated with continued peanut, treenut and sesame ingestion post successful oral food challenge." Journal of Allergy and Clinical Immunology 149, no. 2 (2022): AB103. http://dx.doi.org/10.1016/j.jaci.2021.12.358.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Wood, Robert A. "Clinical Features of Acute Allergic Reactions to Peanut and TreeNuts in Children." Pediatrics 104, Supplement_2 (1999): 364. http://dx.doi.org/10.1542/peds.104.s2.364a.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

CLARK, A., Y. KING, and P. EWAN. "The Clinical Features of Accidental Reactions to Peanuts and Treenuts After Diagnois in Children." Journal of Allergy and Clinical Immunology 121, no. 2 (2008): S253. http://dx.doi.org/10.1016/j.jaci.2007.12.1003.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Hirano, Ikuo, Marc Rothenberg, Evan Dellon, et al. "Dupilumab suppresses type 2 biomarkers of inflammation in patients with eosinophilic esophagitis: from Part B of LIBERTY-EoE-TREET." Journal of Allergy and Clinical Immunology 151, no. 2 (2023): AB199. http://dx.doi.org/10.1016/j.jaci.2022.12.623.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Rothenberg, Marc, Jonathan Spergel, Evan Dellon, et al. "Patients with eosinophilic esophagitis have a high baseline burden of atopic/allergic comorbidities: from Parts A and B of LIBERTY-EoE-TREET." Journal of Allergy and Clinical Immunology 151, no. 2 (2023): AB88. http://dx.doi.org/10.1016/j.jaci.2022.12.279.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Dellon, E., M. Rothenberg, I. Hirano, et al. "DUPILUMAB IMPROVES CLINICAL, SYMPTOMATIC, HISTOLOGIC, ENDOSCOPIC ASPECTS OF EOE: POOLED RESULTS FROM PHASE 3 LIBERTY-EOE-TREET." Annals of Allergy, Asthma & Immunology 129, no. 5 (2022): S25—S34. http://dx.doi.org/10.1016/j.anai.2022.08.603.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Spergel, Jonathan, Lawrence Sher, Sandy Durrani, et al. "Dupilumab improves type 2 comorbidity outcomes in patients with eosinophilic esophagitis and comorbid disease at baseline: from Parts A and B of LIBERTY-EoE-TREET." Journal of Allergy and Clinical Immunology 151, no. 2 (2023): AB199. http://dx.doi.org/10.1016/j.jaci.2022.12.622.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Rothenberg, Marc, Ikuo Hirano, Evan Dellon, et al. "Dupilumab Reduces Biomarkers of Type 2 Inflammation in Adult and Adolescent Patients With Eosinophilic Esophagitis: Results From Parts A and C of a Three-Part, Phase 3 LIBERTY EoE TREET Study." Journal of Allergy and Clinical Immunology 149, no. 2 (2022): AB210. http://dx.doi.org/10.1016/j.jaci.2021.12.688.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Rothenberg, Marc, Evan Dellon, Albert Bredenoord, et al. "Dupilumab Improves Clinical and Histologic Aspects of Disease in Adult and Adolescent Patients With Eosinophilic Esophagitis at Week 24: Results from Part B of the 3-Part LIBERTY EoE TREET Study." Journal of Allergy and Clinical Immunology 149, no. 2 (2022): AB312. http://dx.doi.org/10.1016/j.jaci.2021.12.003.

Full text
APA, Harvard, Vancouver, ISO, and other styles
11

Dellon, E. S., M. E. Rothenberg, M. H. Collins, et al. "Dupilumab safety and efficacy up to 52 weeks in adult and adolescent patients with eosinophilic esophagitis: Results from part A and C of a randomized, placebo-controlled, three-part, phase 3 LIBERTY EoE TREET Study." Revue Française d'Allergologie 62, no. 3 (2022): 372. http://dx.doi.org/10.1016/j.reval.2022.02.199.

Full text
APA, Harvard, Vancouver, ISO, and other styles
12

Dellon, E. S., M. E. Rothenberg, M. H. Collins, et al. "Dupilumab efficacy and safety up to 52 weeks in adult and adolescent patients with eosinophilic esophagitis: Results from parts B and C of the randomized, placebo-controlled, three-part, phase 3 LIBERTY EoE TREET Study." Revue Française d'Allergologie 63, no. 3 (2023): 103594. http://dx.doi.org/10.1016/j.reval.2023.103594.

Full text
APA, Harvard, Vancouver, ISO, and other styles
13

Zirwas, Matthew, Raj Chovatiya, Linda Stein Gold, et al. "564 - Conjunctivitis adverse events in dupilumab clinical trials." British Journal of Dermatology 190, Supplement_2 (2024): ii58—ii59. http://dx.doi.org/10.1093/bjd/ljad498.060.

Full text
Abstract:
Abstract Introduction Dupilumab inhibits signaling of IL-4 and IL-13, key drivers of Type 2 inflammatory diseases such as atopic dermatitis (AD), asthma, chronic rhinosinusitis with nasal polyposis (CRSwNP), eosinophilic esophagitis (EoE), prurigo nodularis (PN), and Chronic Spontaneous Urticaria (CSU).1,2 Adults with AD have a significant and disease severity-dependent increased risk of developing ocular surface diseases, including conjunctivitis and keratitis, compared with the general population.3 In randomized placebo-controlled trials of dupilumab in patients with moderate-to-severe AD, m
APA, Harvard, Vancouver, ISO, and other styles
14

Ta, Von, Brittany Weldon, Grace Yu, Olivier Humblet, Susan Neale-May, and Kari Nadeau. "Use of Specific IgE and Skin Prick Test to Determine Clinical Reaction Severity." September 9, 2011. https://doi.org/10.5281/zenodo.7803.

Full text
Abstract:
Aims: To determine whether specific IgE and skin prick test correlate better in predicting reaction severity during a double-blinded placebo controlled food challenge (DBPCFC) for egg, milk, and multiple tree nut allergens. Study design: Prospective study. Place and Duration of Study: Department of Pediatrics, Stanford University School of Medicine, August 2009 and ongoing. Methodology: We examined the reaction severity of twenty-four subjects to nine possible food allergens: milk, egg, almond, cashew, hazelnut, peanut, sesame, pecan and walnut. Specific IgE and SPT were performed before each
APA, Harvard, Vancouver, ISO, and other styles
15

Ta, Von, Brittany Weldon, Grace Yu, Olivier Humblet, Susan Neale-May, and Kari Nadeau. "Use of Specific IgE and Skin Prick Test to Determine Clinical Reaction Severity." September 9, 2011. https://doi.org/10.5281/zenodo.7784.

Full text
Abstract:
Aims: To determine whether specific IgE and skin prick test correlate better in predicting reaction severity during a double-blinded placebo controlled food challenge (DBPCFC) for egg, milk, and multiple tree nut allergens. Study design: Prospective study. Place and Duration of Study: Department of Pediatrics, Stanford University School of Medicine, August 2009 and ongoing. Methodology: We examined the reaction severity of twenty-four subjects to nine possible food allergens: milk, egg, almond, cashew, hazelnut, peanut, sesame, pecan and walnut. Specific IgE and SPT were performed before each
APA, Harvard, Vancouver, ISO, and other styles
16

McWilliam, Vicki L., Jennifer J. Koplin, Katie Allen, et al. "TreEAT trial: Protocol for a randomized controlled trial investigating the efficacy and safety of early introduction of tree nuts for the prevention of tree nut allergy in infants with peanut allergy." Pediatric Allergy and Immunology 34, no. 3 (2023). http://dx.doi.org/10.1111/pai.13930.

Full text
APA, Harvard, Vancouver, ISO, and other styles
17

"P29: TREEAT TRIAL: PROTOCOL FOR A RANDOMISED CONTROLLED TRIAL INVESTIGATING THE EFFICACY AND SAFETY OF EARLY INTRODUCTION OF TREE NUTS FOR THE PREVENTION OF TREE NUT ALLERGY IN INFANTS WITH PEANUT ALLERGY." Internal Medicine Journal 52, S5 (2022): 12. http://dx.doi.org/10.1111/imj.28_15894.

Full text
APA, Harvard, Vancouver, ISO, and other styles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography